I wasn't explicitly taking a position on that issue, but rather suggesting that the "who" is more important than the how.

"Co-leads" can mean different things, and in any nomenclature having two funds in roughly equal positions in an early-stage round can be great... and can also have unintended and significant consequences.

If you're not aware of these nuances, please add a seasoned advisor to your team asap.